Applicant, as named in the Orange Book
Foldrx Pharms
Next listed expiry: Vyndamax on 31 Aug 2035. 1 products with live protection, 0 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Vyndamax tafamidis | 31 Aug 2035 |
Recent events
- 24 Oct 2026Vyndaqel ยท Enters 12-month window basis: patent19 Dec 2026